DYNT vs. NMRD, QNRX, INVO, TNON, RSLS, GMVDF, OSAP, OSA, IONM, and AEMD
Should you be buying Dynatronics stock or one of its competitors? The main competitors of Dynatronics include Nemaura Medical (NMRD), Quoin Pharmaceuticals (QNRX), INVO Bioscience (INVO), Tenon Medical (TNON), ReShape Lifesciences (RSLS), G Medical Innovations (GMVDF), ProSomnus (OSAP), ProSomnus (OSA), Assure (IONM), and Aethlon Medical (AEMD). These companies are all part of the "surgical & medical instruments" industry.
Nemaura Medical (NASDAQ:NMRD) and Dynatronics (NASDAQ:DYNT) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their community ranking, valuation, institutional ownership, analyst recommendations, dividends, earnings, profitability, risk and media sentiment.
Dynatronics has higher revenue and earnings than Nemaura Medical. Dynatronics is trading at a lower price-to-earnings ratio than Nemaura Medical, indicating that it is currently the more affordable of the two stocks.
Nemaura Medical currently has a consensus target price of $2.50, indicating a potential upside of 5,713.28%. Dynatronics has a consensus target price of $3.80, indicating a potential upside of 743.13%. Given Dynatronics' stronger consensus rating and higher probable upside, research analysts clearly believe Nemaura Medical is more favorable than Dynatronics.
In the previous week, Dynatronics had 1 more articles in the media than Nemaura Medical. MarketBeat recorded 1 mentions for Dynatronics and 0 mentions for Nemaura Medical. Dynatronics' average media sentiment score of 0.00 equaled Nemaura Medical'saverage media sentiment score.
Dynatronics received 305 more outperform votes than Nemaura Medical when rated by MarketBeat users. However, 57.14% of users gave Nemaura Medical an outperform vote while only 50.91% of users gave Dynatronics an outperform vote.
Nemaura Medical has a beta of 0.04, meaning that its stock price is 96% less volatile than the S&P 500. Comparatively, Dynatronics has a beta of 0.41, meaning that its stock price is 59% less volatile than the S&P 500.
Nemaura Medical has a net margin of 0.00% compared to Nemaura Medical's net margin of -14.13%. Dynatronics' return on equity of 0.00% beat Nemaura Medical's return on equity.
4.4% of Nemaura Medical shares are owned by institutional investors. Comparatively, 4.2% of Dynatronics shares are owned by institutional investors. 41.6% of Nemaura Medical shares are owned by company insiders. Comparatively, 9.1% of Dynatronics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
Summary
Nemaura Medical beats Dynatronics on 11 of the 17 factors compared between the two stocks.
Get Dynatronics News Delivered to You Automatically
Sign up to receive the latest news and ratings for DYNT and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding DYNT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Dynatronics Competitors List
Related Companies and Tools
